SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Search Videos by Topic or Participant

A unqiue opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

Select Topic:

Browse by Series:

Immuno-Oncology in Advanced Lung Cancer

Future Directions in NSCLC Immuno-Oncology Research

Immuno-Oncology Combination Therapy in NSCLC

Promising Immunotherapy Agents for NSCLC

PACIFIC Trial: Durvalumab for Stage 3 NSCLC

Immunotherapy for Management of Stage 3B NSCLC

Immunotherapy Toxicity Management in NSCLC

Treatment for NSCLC After Progression on Immunotherapy

Combination Approaches for Second-Line Therapy for NSCLC

The Role of Mutation Burden as a Biomarker in NSCLC

Next Page >>

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More